Characteristics of the population with type 2 diabetes, according to retinopathy status: the AusDiab study
. | Retinopathy . | No retinopathy . | P . |
---|---|---|---|
n | 96 | 607 | |
Age (years) | 65 ± 11 | 62 ± 12 | 0.016 |
Male (%) | 45 | 51 | 0.241 |
Fasting plasma glucose (mmol/l) | 10.2 ± 4.5 | 7.9 ± 2.4 | <0.001 |
HbA1c (%) | 7.4 (5.9–8.5) | 6.0 (5.6–6.8) | <0.001 |
Known diabetes (%) | 76 | 43 | <0.001 |
Duration of diabetes (years)* | 7 (0–15) | 0 (0–4) | <0.001 |
On insulin or tablets (%) | 82 | 65 | 0.004 |
BMI (kg/m2) | 30.3 ± 5.6 | 30.2 ± 6.1 | 0.984 |
Cholesterol (mmol/l) | 5.5 ± 1.0 | 5.7 ± 1.0 | 0.115 |
Triglycerides (mmol/l) | 1.8 (1.3–2.6) | 1.9 (1.3–2.7) | 0.572 |
Current smoker (%) | 11 | 9 | 0.574 |
Hypertension (%) | 72 | 66 | 0.288 |
SBP (mmHg) | 148 ± 24 | 140 ± 18 | <0.001 |
DBP (mmHg) | 78 ± 10 | 79 ± 10 | 0.415 |
C-peptide (ng/ml) | 3.2 ± 1.7 | 3.8 ± 1.7 | 0.001 |
Urinary albumin:creatinine ratio (mg/mmol) | 1.72 (0.8–6.3) | 0.97 (0.6–2.3) | <0.001 |
. | Retinopathy . | No retinopathy . | P . |
---|---|---|---|
n | 96 | 607 | |
Age (years) | 65 ± 11 | 62 ± 12 | 0.016 |
Male (%) | 45 | 51 | 0.241 |
Fasting plasma glucose (mmol/l) | 10.2 ± 4.5 | 7.9 ± 2.4 | <0.001 |
HbA1c (%) | 7.4 (5.9–8.5) | 6.0 (5.6–6.8) | <0.001 |
Known diabetes (%) | 76 | 43 | <0.001 |
Duration of diabetes (years)* | 7 (0–15) | 0 (0–4) | <0.001 |
On insulin or tablets (%) | 82 | 65 | 0.004 |
BMI (kg/m2) | 30.3 ± 5.6 | 30.2 ± 6.1 | 0.984 |
Cholesterol (mmol/l) | 5.5 ± 1.0 | 5.7 ± 1.0 | 0.115 |
Triglycerides (mmol/l) | 1.8 (1.3–2.6) | 1.9 (1.3–2.7) | 0.572 |
Current smoker (%) | 11 | 9 | 0.574 |
Hypertension (%) | 72 | 66 | 0.288 |
SBP (mmHg) | 148 ± 24 | 140 ± 18 | <0.001 |
DBP (mmHg) | 78 ± 10 | 79 ± 10 | 0.415 |
C-peptide (ng/ml) | 3.2 ± 1.7 | 3.8 ± 1.7 | 0.001 |
Urinary albumin:creatinine ratio (mg/mmol) | 1.72 (0.8–6.3) | 0.97 (0.6–2.3) | <0.001 |
Data are mean ± SD or median (interquartile range).
Newly diagnosed participants given duration of zero. DBP, diastolic blood pressure.